|
1.
|
Kreck C and Saller R: Indischer Weihrauch
und seine Zubereitungen einschliesslich H15 als traditionelles und
modernes Therapeutikum. Internist Prax. 38:857–872. 1998.
|
|
2.
|
Abdel-Tawab M, Werz O and
Schubert-Zsilavecz M: Boswellia serrata: An overall
assessment of in vitro, preclinical, pharmacokinetic and
clinical data. Clin Pharmacokinet. 50:349–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Basch E, Boon H, Davies-Heerema T, Foppo
I, Hashmi S, Hasskarl J, Sollars D and Ulbricht C:
Boswellia: An evidence-based systematic review by the
Natural Standard Research Collaboration. J Herb Pharmacother.
4:63–83. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Gerbeth K, Meins J, Kirste S, Momm F,
Schubert-Zsilavecz M and Abdel-Tawab M: Determination of major
boswellic acids in plasma by high-pressure liquid
chromatography/mass spectrometry. J Pharm Biomed Anal. 56:998–1005.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Poeckel D and Werz O: Boswellic acids:
Biological actions and molecular targets. Curr Med Chem.
13:3359–3369. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Streffer JR, Bitzer M, Schabet M, Dichgans
J and Weller M: Response of radiochemotherapy-associated cerebral
edema to a phytotherapeutic agent, H15. Neurology. 56:1219–1221.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kirste S, Treier M, Wehrle SJ, Becker G,
Abdel-Tawab M, Gerbeth K, Hug MJ, Lubrich B, Grosu AL and Momm F:
Boswellia serrata acts on cerebral edema in patients
irradiated for brain tumors: A prospective, randomized,
placebo-controlled, double-blind pilot trial. Cancer.
117:3788–3795. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Glaser T, Winter S, Groscurth P, Safayhi
H, Sailer ER, Ammon HP, Schabet M and Weller M: Boswellic acids and
malignant glioma: Induction of apoptosis but no modulation of drug
sensitivity. Br J Cancer. 80:756–765. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Winking M, Sarikaya S, Rahmanian A,
Jödicke A and Böker DK: Boswellic acids inhibit glioma growth: A
new treatment option? J Neurooncol. 46:97–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Weller M, van den Bent M, Hopkins K, Tonn
JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D,
Henriksson R, Balana C, et al: EANO guideline for the diagnosis and
treatment of anaplastic gliomas and glioblastoma. Lancet Oncol.
15:e395–e403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Günther HS, Schmidt NO, Phillips HS,
Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal
M and Lamszus K: Glioblastoma-derived stem cell-enriched cultures
form distinct subgroups according to molecular and phenotypic
criteria. Oncogene. 27:2897–2909. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Webb JL: Enzyme and Metabolic Inhibitors.
1:New York, NY: Academic Press. 55–79, and pp 488–512. 1963.
|
|
13.
|
Wischhusen J, Naumann U, Ohgaki H,
Rastinejad F and Weller M: CP-31398, a novel p53-stabilizing agent,
induces p53-dependent and p53-independent glioma cell death.
Oncogene. 22:8233–8245. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Hermisson M, Klumpp A, Wick W, Wischhusen
J, Nagel G, Roos W, Kaina B and Weller M: O6-methylguanine DNA
methyltransferase and p53 status predict temozolomide sensitivity
in human malignant glioma cells. J Neurochem. 96:766–776. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Gerbeth K, Hüsch J, Fricker G, Werz O,
Schubert-Zsilavecz M and Abdel-Tawab M: In vitro metabolism,
permeation and brain availability of six major boswellic acids from
Boswellia serrata gum resins. Fitoterapia. 84:99–106. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Reising K, Meins J, Bastian B, Eckert G,
Mueller WE, Schubert-Zsilavecz M and Abdel-Tawab M: Determination
of boswellic acids in brain and plasma by high-performance liquid
chromatography/tandem mass spectrometry. Anal Chem. 77:6640–6645.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Charles NA, Holland EC, Gilbertson R,
Glass R and Kettenmann H: The brain tumor microenvironment. Glia.
59:1169–1180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Fujita M, Kohanbash G, Fellows-Mayle W,
Hamilton RL, Komohara Y, Decker SA, Ohlfest JR and Okada H: COX-2
blockade suppresses gliomagenesis by inhibiting myeloid-derived
suppressor cells. Cancer Res. 71:2664–2674. 2011. View Article : Google Scholar : PubMed/NCBI
|
